Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada.

Background: Administration of magnesium sulphate (MgSO4) to women with imminent preterm birth at <34 weeks is an evidence-based antenatal neuroprotective strategy to prevent cerebral palsy. Although a Society of Obstetricians and Gynaecologists of Canada (SOGC) national guideline with practice recom...

Descripción completa

Detalles Bibliográficos

Publicado en:	BMC Pregnancy & Childbirth Vol. 15; pp. 1 - 14
Autores principales:	Teela, Katherine C., De Silva, Dane A., Chapman, Katie, Synnes, Anne R., Sawchuck, Diane, Basso, Melanie, Liston, Robert M., von Dadelszen, Peter, Magee, Laura A.
Formato:	research Journal Article
Publicado:	BioMed Central 12/22/2015
Acceso en línea:	Ver este registro en EBSCOhost